|
Index of reports
> Cases resulting in other serious reactions (86)
> Cases with Dyspnoea (9)
Below is the selection of adverse event reports related to Aldactone (Spironolactone) that includes cases resulting in other serious reactions where reactions include dyspnoea.
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-10-26
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Injection Site Haematoma, Coagulopathy, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Depression, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Olmetec
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Novonorm
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a physician from Australia on 2007-10-19
Patient: male, weighing 130.0 kg (286.0 pounds)
Adverse reactions / side effects: Pulmonary Hypertension, Dyspnoea, Pneumonia, Anaemia, Encephalopathy, Tricuspid Valve Incompetence, Surgery, Cardiac Failure, Mitral Valve Incompetence, Oedema Peripheral, Sleep Apnoea Syndrome, Alcohol Problem
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Oedema
Lipitor
Dosage: daily dose:20mg
Administration route: Oral
Indication: Hyperlipidaemia
Other drugs received by patient: Atacand; Lasix; Dilatrend; Endep; Warfarin Sodium; Zyloprim; Diaformin
Adverse event in 57 year old male receiving Aldactone (Spironolactone)
Reported by a pharmacist from Japan on 2007-10-02
Patient: 57 year old male, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Dyspnoea, Pericardial Effusion, Haemoglobin Decreased, Haematocrit Decreased, Thrombocytopenic Purpura, Platelet Count Decreased, Haemorrhagic Diathesis, Rash Maculo-Papular
Adverse event resulted in: life threatening event
Suspect drug(s):
Lasix
Dosage: 20 mg/day
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2007-06-12
End date: 2007-07-13
Aldactone
Dosage: 25 mg/day
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2007-06-27
End date: 2007-07-20
Tenormin
Dosage: 25 mg/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2004-04-01
End date: 2007-07-20
Micardis
Dosage: 20 mg/day
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2004-04-01
End date: 2007-07-20
Warfarin Sodium
Dosage: 3 mg/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2007-06-07
End date: 2007-07-09
Propylthiouracil
Dosage: 300 mg/day
Administration route: Oral
Start date: 1987-01-01
End date: 2007-07-12
Propylthiouracil
Dosage: 200 mg/day
Administration route: Oral
Start date: 2007-07-13
End date: 2007-07-20
Propylthiouracil
Dosage: 300 mg/day
Administration route: Oral
Start date: 2007-08-03
Mucosta
Dosage: 300 mg/day
Administration route: Oral
Indication: Gastric Mucosal Lesion
Start date: 2007-05-18
End date: 2007-07-13
Sigmart
Dosage: 15 mg/day
Administration route: Oral
Indication: Angina Pectoris
Start date: 2004-04-01
End date: 2007-07-13
Bepricor
Dosage: 150 mg/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2007-07-02
End date: 2007-07-20
Nitroderm
Dosage: 1 patch/day
Indication: Angina Pectoris
Start date: 2007-07-13
Amlodipine Besylate
Indication: Angina Pectoris
Start date: 2004-04-01
Aspirin
Dosage: 100mg
Administration route: Oral
End date: 2007-07-12
Other drugs received by patient: Unasyn; Gentacin
Adverse event in receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from France on 2007-07-26
Patient:
Adverse reactions / side effects: LOW Cardiac Output Syndrome, Vomiting, Dyspnoea, Hyperkalaemia, Drug Interaction, Haemodialysis, Cardiac Failure, Renal Tubular Necrosis, Hypoperfusion, Blood Creatinine Increased, Renal Failure Acute, Anuria
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Administration route: Oral
End date: 2007-05-08
Lasilix / 00032601 /
Administration route: Oral
End date: 2007-05-08
Cordarone / 00133102 /
Dosage: 200 mg, unk
Administration route: Oral
Aldactone
Administration route: Oral
End date: 2007-05-08
Celebrex
Administration route: Oral
Indication: Pain in Extremity
Other drugs received by patient: Previscan / 00789001 /
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-05-08
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Olmetec
Administration route: Oral
Indication: Hypertension
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-05-01
Patient: female
Adverse reactions / side effects: Dyspnoea, Drug Ineffective, Syncope, Fatigue, Malaise, Palpitations, Arterial Occlusive Disease, Oedema, Pulmonary Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Olmetec
Administration route: Oral
Indication: Hypertension
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-04-02
Patient: female
Adverse reactions / side effects: Dyspnoea, Malaise, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Olmetec
Dosage: daily dose:20mg
Administration route: Oral
Caduet
Administration route: Oral
Aldactone
Dosage: text:5/10 mg (milligram)
Administration route: Oral
Coristina D
Administration route: Oral
Insulin
Indication: Diabetes Mellitus
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-03-20
Patient: female
Adverse reactions / side effects: Dyspnoea, Malaise, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Olmetec
Administration route: Oral
Caduet
Administration route: Oral
Aldactone
Administration route: Oral
Coristina D
Administration route: Oral
Insulin
Adverse event in 78 year old female receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-17
Patient: 78 year old female
Adverse reactions / side effects: Dyspnoea, Hypotension, Vertigo
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Perindopril Erbumine
Administration route: Oral
Indication: Cardiac Failure
Atacand
Administration route: Oral
Indication: Cardiac Failure
Other drugs received by patient: Desloratadine; Omeprazole; Previscan
|
